NM_002863.5(PYGL):c.93T>C (p.Ser31=) AND not provided

Germline classification:: Benign (2 submissions)
Last evaluated:: May 5, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000675375.7

Allele description [Variation Report for NM_002863.5(PYGL):c.93T>C (p.Ser31=)]

NM_002863.5(PYGL):c.93T>C (p.Ser31=)

Gene:

PYGL:glycogen phosphorylase L [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

14q22.1

Genomic location:

Preferred name:

NM_002863.5(PYGL):c.93T>C (p.Ser31=)

HGVS:

NC_000014.9:g.50944311A>G
NG_012796.1:g.5220T>C
NM_001163940.2:c.93T>C
NM_002863.5:c.93T>CMANE SELECT
NP_001157412.1:p.Ser31=
NP_002854.3:p.Ser31=
NC_000014.8:g.51411029A>G
NM_002863.4:c.93T>C

Links:

dbSNP: rs17123244

NCBI 1000 Genomes Browser:

rs17123244

Molecular consequence:

NM_001163940.2:c.93T>C - synonymous variant - [Sequence Ontology: SO:0001819]
NM_002863.5:c.93T>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000801041	Mayo Clinic Laboratories, Mayo Clinic	no assertion criteria provided	Benign (Apr 24, 2017)	unknown	clinical testing
SCV001758117	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Benign (May 5, 2021)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000801041

Mayo Clinic Laboratories, Mayo Clinic

no assertion criteria provided

Benign
(Apr 24, 2017)

unknown

clinical testing

SCV001758117

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Benign
(May 5, 2021)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Mayo Clinic Laboratories, Mayo Clinic, SCV000801041.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From GeneDx, SCV001758117.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 10, 2024

ClinVar

Relating variation to medicine